Ionis Pharmaceuticals, Inc. (LON:0JDI)
London · Delayed Price · Currency is GBP · Price in USD 82.09
-1.18 (-1.41%)
Feb 12, 2026, 5:08 PM GMT
Ionis Pharmaceuticals Market Cap
Ionis Pharmaceuticals has a market cap or net worth of 10.01 billion as of February 12, 2026. Its market cap has increased by 131.22% in one year.
Market Cap
10.01B
Enterprise Value
9.88B
Revenue
719.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
82.09
Market Cap Chart
Since May 17, 1991, Ionis Pharmaceuticals's market cap has increased from 61.76M to 10.01B, an increase of 16,114.53%. That is a compound annual growth rate of 15.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 10.01B | 5.18% |
| Dec 31, 2025 | 9.52B | 115.92% |
| Dec 31, 2024 | 4.41B | -22.62% |
| Dec 29, 2023 | 5.70B | 27.97% |
| Dec 30, 2022 | 4.45B | 40.32% |
| Dec 31, 2021 | 3.17B | -45.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |